Among these, the inhibition of transcriptional enhanced associate domain (TEAD) and hematopoietic progenitor kinase 1 (HPK1) has emerged as a promising approach to addressing various devastating diseases including cancer. The gene discussed is MAP4K1; the disease is cancer.